Spots Global Cancer Trial Database for cin 2
Every month we try and update this database with for cin 2 cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
---|---|---|---|---|---|---|
REVEAL 1 (Evaluation of VGX-3100 and Electroporation for the Treatment of Cervical HSIL) | NCT03185013 | Cervical Dyspla... Cervical High G... HSIL | VGX-3100 Placebo Electroporation... | 18 Years - | Inovio Pharmaceuticals | |
Natural History of HPV From Infection to Neoplasia in Adolescents and Young Women | NCT01366742 | Human Papilloma... CIN 2 CIN 3 | 13 Years - 22 Years | University of California, Los Angeles | ||
REVEAL 1 (Evaluation of VGX-3100 and Electroporation for the Treatment of Cervical HSIL) | NCT03185013 | Cervical Dyspla... Cervical High G... HSIL | VGX-3100 Placebo Electroporation... | 18 Years - | Inovio Pharmaceuticals | |
Natural History of HPV From Infection to Neoplasia in Adolescents and Young Women | NCT01366742 | Human Papilloma... CIN 2 CIN 3 | 13 Years - 22 Years | University of California, Los Angeles | ||
Validation of Implementation of Cervical Dysplasia Treatment Modalities in HIV-Seropositive Women | NCT01723956 | Cervical Intrae... | Cryotherapy LEEP | 18 Years - 65 Years | University of Witwatersrand, South Africa | |
REVEAL 2 Trial (Evaluation of VGX-3100 and Electroporation for the Treatment of Cervical HSIL) | NCT03721978 | Cervical Dyspla... Cervical High G... HSIL | VGX-3100 Placebo CELLECTRA™-5PSP | 18 Years - | Inovio Pharmaceuticals |